Regencell Bioscience Holdings Ltd Quarterly Liabilities and Equity in USD from Q2 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Regencell Bioscience Holdings Ltd quarterly Liabilities and Equity history and growth rate from Q2 2020 to Q2 2024.
Regencell Bioscience Holdings Ltd Liabilities and Equity for the quarter ending June 30, 2024 was $8.44M, a 33.1% decline year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$8.44M	-$4.18M	-33.1%	Jun 30, 2024	20-F	2024-10-25
Q2 2023	$12.6M	-$5.4M	-30%	Jun 30, 2023	20-F	2024-10-25
Q2 2022	$18M	+$17.7M	+5198%	Jun 30, 2022	20-F	2023-10-27
Q2 2021	$340K	-$174K	-33.8%	Jun 30, 2021	20-F	2022-10-31
Q2 2020	$514K			Jun 30, 2020	20-F	2021-10-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.